AI drug development | pharmaphorum

Wednesday 23 April 2025

Channels

Content type

Categories

Categories

Sort by

Order

AI drug development

Digital

pharmaphorum podcast Episode 169a

GenAI and the revolution of drug development

Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.

Sales & Marketing

decision making blocks

Improving patient engagement and drug development through AI...

Although it might seem like AI is the newest and hottest innovation in the industry, medical affairs professionals have been using some form of it for decades

R&D

artificial intelligence

Transforming drug development with AI

From streamlining clinical trials to evaluating drug repurposing possibilities for new patient populations and addressing critical supply chain challenges, 2024 will be the year artificial

Market Access

Six takeaways from JP Morgan 2024

Six takeaways from JP Morgan 2024

With another JP Morgan in the rearview mirror, it’s time to take stock of the announcements, the presentations, and, above all, the vibes.

R&D

molecule model

Solving the hit-to-lead selection challenge for novel target...

The drug target universe is expanding to include RNA and protein-protein interactions, but poor-quality data is holding back progress.

R&D

Future of generative AI

Future of generative AI in pharma

Talk of implementing automation and AI to enhance human capacity is dominating conversations.